Figure 3.
Figure 3. VCAM-1 inhibits neutrophil but not lymphocyte apoptosis. (A) CD31, ICAM-1, and VCAM-1 were immobilized at the concentrations shown (micrograms per milliliter) and neutrophils added for 18 hours before apoptosis was measured by DiOC6 staining. Results are expressed as the percentage of apoptotic neutrophils compared with neutrophils cultured in medium alone; mean ± SD of 3 separate experiments. (B) VCAM-1 was immobilized in a 96-well plate, and neutrophils were added in the absence (□) or presence (▪) of 1000 U/mL IFN-β. After 18 hours, apoptosis was measured by DiOC6 staining. (C) Cells from a CD4 T-cell line were incubated in the presence or absence of the survival factors IL-2 (50 U/mL), IFN-β (1000 U/mL), or sVCAM-1 (10 μg/mL). Apoptosis was measured by DiOC6 staining. Data in panels B-C are from a single experiment that is representative of 3 performed.

VCAM-1 inhibits neutrophil but not lymphocyte apoptosis. (A) CD31, ICAM-1, and VCAM-1 were immobilized at the concentrations shown (micrograms per milliliter) and neutrophils added for 18 hours before apoptosis was measured by DiOC6 staining. Results are expressed as the percentage of apoptotic neutrophils compared with neutrophils cultured in medium alone; mean ± SD of 3 separate experiments. (B) VCAM-1 was immobilized in a 96-well plate, and neutrophils were added in the absence (□) or presence (▪) of 1000 U/mL IFN-β. After 18 hours, apoptosis was measured by DiOC6 staining. (C) Cells from a CD4 T-cell line were incubated in the presence or absence of the survival factors IL-2 (50 U/mL), IFN-β (1000 U/mL), or sVCAM-1 (10 μg/mL). Apoptosis was measured by DiOC6 staining. Data in panels B-C are from a single experiment that is representative of 3 performed.

Close Modal

or Create an Account

Close Modal
Close Modal